MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

BioTelemetry Company Profile (NASDAQ:BEAT)

Consensus Ratings for BioTelemetry (NASDAQ:BEAT) (?)
Ratings Breakdown: 1 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $20.00 (22.77% upside)

Analysts' Ratings History for BioTelemetry (NASDAQ:BEAT)
Show:
DateFirmActionRatingPrice TargetActions
7/28/2015Dougherty & CoBoost Price TargetBuy$18.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/24/2014Avondale PartnersUpgradeMarket Perform -> OutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 6/30/2014 forward)
Earnings History for BioTelemetry (NASDAQ:BEAT)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallActions
8/4/2016        
4/26/2016Q1$0.10$0.20$46.54 million$48.60 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2016Q415$0.11$0.15$45.89 million$46.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/9/2015Q3$0.11$0.13$46.05 million$43.49 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/6/2015Q2$0.09$0.12$45.75 million$44.81 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2015Q115$0.02$0.06$43.80 million$43.40 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/19/2015Q414$0.06$0.05$43.40 million$43.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
10/30/2014Q214$0.02$0.06$42.00 million$43.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/31/2014Q114$0.01$0.02$40.95 million$42.70 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/6/2014Q413($0.02)($0.04)$38.40 million$37.16 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/26/2014Q313($0.04)$0.05$32.26 million$33.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2013($0.05)($0.12)$32.79 million$31.90 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
7/30/2013Q2 2013$0.02$27.50 million$32.10 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/13/2013Q4 2012($0.09)$26.80 million$30.00 millionViewListenView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/5/2012Q312($0.09)($0.08)$26.49 million$27.00 millionViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2012($0.04)($0.01)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/8/2012($0.12)($0.10)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/22/2012($0.13)($0.04)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
11/8/2011($0.09)($0.21)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
8/8/2011($0.06)($0.05)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
5/3/2011($0.15)($0.02)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
2/17/2011($0.16)($0.13)ViewN/AView Earnings Details  Tweet This Announcement  Share This Announcement on StockTwits
(Data available from 1/1/2011 forward)
Earnings Estimates for BioTelemetry (NASDAQ:BEAT)
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20162$0.08$0.09$0.09
Q2 20161$0.16$0.16$0.16
Q3 20162$0.14$0.16$0.15
Q4 20161$0.16$0.16$0.16
Q1 20171$0.17$0.17$0.17
Q2 20171$0.18$0.18$0.18
Q3 20171$0.18$0.18$0.18
Q4 20171$0.18$0.18$0.18
(Data provided by Zacks Investment Research)
Dividend History for BioTelemetry (NASDAQ:BEAT)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for BioTelemetry (NASDAQ:BEAT)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionActions
5/9/2014Ronald AhrensDirectorBuy6,000$7.37$44,220.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2013Ronald AhrensDirectorBuy5,000$11.73$58,650.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
11/12/2012Ronald A AhrensDirectorBuy15,000$2.22$33,300.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
9/5/2012Joseph H CapperCEOBuy23,540$2.25$52,965.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/31/2012Joseph H CapperCEOBuy2,600$2.28$5,928.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/29/2012Joseph H CapperCEOBuy10,800$2.30$24,840.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/28/2012Joseph H CapperCEOBuy1,300$2.19$2,847.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/27/2012Joseph H CapperCEOBuy1,600$2.12$3,392.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/23/2012Joseph H CapperCEOBuy9,600$2.08$19,968.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/20/2012Joseph H CapperCEOBuy14,160$1.97$27,895.20View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
8/17/2012Joseph H CapperCEOBuy9,800$2.10$20,580.00View SEC Filing  Tweet This Trade  Share This Trade on StockTwits
(Data available from 1/1/2013 forward)
Latest Headlines for BioTelemetry (NASDAQ:BEAT)
DateHeadline
06/29/16 10:59 AMRecently Issued Stock Ratings For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard
06/28/16 07:15 AMBioTelemetry, Inc. breached its 50 day moving average in a Bearish Manner : BEAT-US : June 28, 2016 -
06/27/16 02:26 PMBioTelemetry, Inc. (NASDAQ:BEAT) Broker Price Targets For The Coming Week - Fiscal Standard
06/25/16 02:46 PMStrong Sell Calls Recommendations For BioTelemetry, Inc. (NASDAQ:BEAT) At 0 - Investor Newswire
06/24/16 07:56 PMBioTelemetry, Inc. versus BioScrip, Inc. Head to Head Compare - CML News
06/22/16 07:55 PMNew Broker Ratings For BioTelemetry, Inc. (NASDAQ:BEAT) - FTSE News
06/21/16 07:32 AMBioTelemetry, Inc. (NASDAQ:BEAT) Current Analyst Ratings - Fiscal Standard
06/20/16 10:07 AMGap-up Opens Just Aren't What They Used to Be -
06/19/16 02:41 PMThis Weeks Broker Views For BioTelemetry, Inc. (NASDAQ:BEAT) - Fiscal Standard
06/19/16 07:28 AMStrong Buy Calls Count For BioTelemetry, Inc. (NASDAQ:BEAT) At 1 - Investor Newswire
06/12/16 11:00 AM5 Trade Ideas for Monday: BioTelemetry, CBOE, Honeywell, Intuitive Surgical and Mastercard -
06/09/16 11:43 AMNewly released market study: CardioNet, Inc. (BEAT) - Financial and Strategic SWOT Analysis Review
06/03/16 11:21 AMBioTelemetry, Inc. (NASDAQ:BEAT) Do Brokers Advise Buy, Sell Or Hold? - Share Trading News
06/01/16 02:52 PMBioTelemetry, Inc. (BEAT) Hits a New 52-Week High - Finance Daily - BioTelemetry, Inc. (BEAT) Hits a New 52-Week HighFinance DailyThe stock of BioTelemetry, Inc. (NASDAQ:BEAT) exerienced a new one year high price at $17.68 on Tuesday. The stock closed up 1.70% ending the day at $17.35. Volume came in at 657,930 and the stock hit a low of $17.04 during the day. Company shares ...
06/01/16 11:19 AMBuy, Sell Or Hold Rating For BioTelemetry, Inc. (NASDAQ:BEAT)? - Share Trading News - Buy, Sell Or Hold Rating For BioTelemetry, Inc. (NASDAQ:BEAT)?Share Trading NewsBioTelemetry, Inc. has a 50 day moving average of 14.43 and a 200 day moving average of 12.29. The stock's market capitalization is 485.91M, it has a 52-week low of 8.74 and a 52-week high of 17.68. The share price of the company (NASDAQ:BEAT) was ...Stock Trending Up: BioTelemetry, Inc. (NASDAQ:BEAT)The Postall 2 news articles »
05/31/16 08:31 PMShares Touching a Recent High: BioTelemetry, Inc. (NASDAQ:BEAT) - HNN - Shares Touching a Recent High: BioTelemetry, Inc. (NASDAQ:BEAT)HNNBioTelemetry, Inc. (NASDAQ:BEAT)'s stock has seen a steady move upward, reaching $17.56 on a recent bid, generating strong interest amongst investors and analysts alike. Shareholders are noting a Return on Investment (ROI) of 9.10%. Return on ...and more »
05/28/16 07:11 PMBioTelemetry, Inc. Stock Was Bought By Options Traders - HNN - BioTelemetry, Inc. Stock Was Bought By Options TradersHNNIn today's session BioTelemetry, Inc. (BEAT) registered an unusually high (220) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the June, 2016 call, expecting serious BEAT increase. With 220 contracts ...and more »
05/27/16 03:18 PMYellen's Words of Warning Don't Faze Market -
05/27/16 11:15 AM5 Breakout Stocks Under $20 -
05/26/16 06:19 PMETF’s with exposure to BioTelemetry, Inc. : May 26, 2016 -
05/25/16 07:13 PMPortfolio Of Healthcare Movers: OXiGENE, Inc. (NASDAQ:OXGN) , BioTelemetry, Inc. (NASDAQ:BEAT) - Is stories - Portfolio Of Healthcare Movers: OXiGENE, Inc. (NASDAQ:OXGN) , BioTelemetry, Inc. (NASDAQ:BEAT)Is storiesOXiGENE, Inc. (NASDAQ:OXGN) initiated the shares trading at $0.900 and showed positive change of +50.179% while the stock's final trade was registered at $ 0.838. However, its previous closing price was seen at $0.558. The stock negotiated total number ...and more »
05/25/16 01:43 AMNotable 52-Week Highs and Lows 5/24: (NDSN) (BEAT) (AMAT) High; (DSW) (TWTR) (TOUR) Low - Nordson Corp. sees Q3 2016 EPS of $1.25 - $1.37, versus the consensus of $1.23. BioTelemetry, Inc. (Nasdaq: BEAT) $17.08. BioTelemetry powering back above the $16 level on volume. Applied Materials, Inc. (Nasdaq: AMAT) $23.48. Applied Materials also adding ...
05/22/16 06:42 PMAfter Last Week What Do Analysts Think Of BioTelemetry, Inc. (NASDAQ:BEAT) - Share Trading News - After Last Week What Do Analysts Think Of BioTelemetry, Inc. (NASDAQ:BEAT)Share Trading News06/03/2014 – BioTelemetry, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of BioTelemetry, Inc. (NASDAQ:BEAT) was up +3.52% during the last trading session, with a day high of 15.75. 253872 shares were traded on BioTelemetry, ...
05/19/16 07:27 PMBioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.012 - Stocks Daily - BioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.012Stocks DailyFor the year ended 2015-12-31, BioTelemetry, Inc. (NASDAQ:BEAT)comprehensive income was $-0.012 millions whereas for the quarter ended 2015-12-31, it was $-0.012 millions. BioTelemetry, Inc. (NASDAQ:BEAT) posted $7.428 millions on combined net ...
05/18/16 07:45 PMBioTelemetry, Inc. (NASDAQ:BEAT) Updated Broker Price Targets - Share Trading News - BioTelemetry, Inc. (NASDAQ:BEAT) Updated Broker Price TargetsShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of BioTelemetry, Inc. (NASDAQ:BEAT). The latest reports which are currently in issue on Wednesday 18th of May state 0 analysts have a rating of “strong buy”, 0 analysts ...and more »
05/16/16 12:42 PMBioTelemetry, Inc. (NASDAQ:BEAT) Broker Price Targets For The Coming Week - Share Trading News - BioTelemetry, Inc. (NASDAQ:BEAT) Broker Price Targets For The Coming WeekShare Trading NewsMarket analysts have recently updated their ratings and price targets on shares of BioTelemetry, Inc. (NASDAQ:BEAT). The latest reports which are currently in issue on Sunday 15th of May state 0 analysts have a rating of “strong buy”, 0 analysts “buy”, ...and more »
05/14/16 01:18 AMWhat Will Happen to BioTelemetry, Inc. Next? The Stock Just Increased A Lot - Wall Street Hints and News - What Will Happen to BioTelemetry, Inc. Next? The Stock Just Increased A LotWall Street Hints and NewsThe stock of BioTelemetry, Inc. (NASDAQ:BEAT) is a huge mover today! The stock increased 3.74% or $0.54 during the last trading session, hitting $14.99. About 279,660 shares traded hands or 24.41% up from the average. BioTelemetry, Inc.Biotelemetry Incorporated (NASDAQ:BEAT) Short Interest Decreased By 2.47%Franklin Independentall 2 news articles »
05/12/16 08:56 PMBroker Roundup For BioTelemetry, Inc. (NASDAQ:BEAT) - Share Trading News - Broker Roundup For BioTelemetry, Inc. (NASDAQ:BEAT)Share Trading News06/03/2014 – BioTelemetry, Inc. was downgraded to “sell” by analysts at TheStreet. The share price of BioTelemetry, Inc. (NASDAQ:BEAT) was down -2.53% during the last trading session, with a day high of 15.65. 220309 shares were traded on BioTelemetry ...
05/12/16 08:56 PMBioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.012 For Period Ended 2015-12-31 - Stocks Daily - BioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.012 For Period Ended 2015-12-31Stocks DailyFor the year ended 2015-12-31, BioTelemetry, Inc. (NASDAQ:BEAT)comprehensive income was $-0.012 millions while for the quarter ended 2015-12-31, it was $-0.012 millions. BioTelemetry, Inc. (NASDAQ:BEAT) posted $7.428 millions on consolidated net ...and more »
05/11/16 08:40 PMBioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc. - GlobeNewswire (press release) - BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.GlobeNewswire (press release)MALVERN, Pa., May 11, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today ...BioTelemetry Completes $15 Mil. Acquisition of VirtualScopics (NASDAQ:BEAT)Sonoran Weekly Reviewall 2 news articles »
05/11/16 08:25 AMBioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc. - [GlobeNewswire] - MALVERN, Pa., May 11, 2016-- BioTelemetry, Inc., the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced ...
05/10/16 08:16 PMBioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc. - GlobeNewswire (press release) - BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.GlobeNewswire (press release)MALVERN, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today ...and more »
05/10/16 07:18 AMBioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc. - [at noodls] - MALVERN, Pa., May 10, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life ...
05/09/16 08:00 AMVirtualScopics, Inc. Board Determines Gastineau Partners Proposal Not Reasonably Expected to Lead to a Superior Company Proposal - [PR Newswire] - ROCHESTER, N.Y., May 9, 2016 /PRNewswire/ -- VirtualScopics, Inc. (VSCP), a leading provider of clinical trial imaging solutions, announced today that its Board of Directors, in consultation with its legal and financial advisors, has determined that an unsolicited proposal from a group identifying itself as Gastineau Partners, LLC, to acquire an uncertain number of shares of the Company's outstanding common and preferred stock and purchase newly issued preferred stock at an undetermined price and unspecified rights, preferences and privileges, would not reasonably be expected to lead to a Superior Company Proposal under the terms of its merger agreement with BioTelemetry, Inc. (NASDAQ:BEAT). The Company received the proposal from Gastineau Partners on May 5, 2016, the same day in which Gastineau Partners issued a press release announcing the offer. The Company then contacted Gastineau Partners' representatives solely to clarify the terms of the proposal. The group admitted it does not have committed financing for the purchase at this time. Additionally, under the terms of the proposal and through supplemental information provided by Gastineau Partners, the group would not be bound to acquire 75% or more of the voting power of the Company's outstanding capital stock as required for it to be a Superior Company Proposal under the BioTelemetry merger agreement. Furthermore, the price, rights, privileges and preferences of the newly issued preferred stock to be purchased would be decided only after tenders of common stock were completed. The group would not commit to signing a definitive agreement in less than 45 days.
05/06/16 09:11 PMBioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.01 Millions For Quarter Closed 2016-03-31 - Stocks Daily - BioTelemetry, Inc. (NASDAQ:BEAT) Comprehensive Income At $-0.01 Millions For Quarter Closed 2016-03-31Stocks DailyFor the year ended 2016-03-31, BioTelemetry, Inc. (NASDAQ:BEAT) comprehensive income was $-0.01 millions whereas for the quarter ended 2016-03-31, the comprehensive income was $-0.01 millions. BioTelemetry, Inc. (NASDAQ:BEAT) posted $7.428 ...
05/06/16 09:11 PMBioTelemetry, Inc. Appoints Colin Hill to Its Board of Directors - GlobeNewswire (press release) - BioTelemetry, Inc. Appoints Colin Hill to Its Board of DirectorsGlobeNewswire (press release)MALVERN, Pa., May 06, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the ...and more »
05/06/16 03:24 PMBioTelemetry, Inc. Appoints Colin Hill to Its Board of Directors - [at noodls] - MALVERN, Pa., May 06, 2016 (GLOBE NEWSWIRE) -- BioTelemetry, Inc. (NASDAQ:BEAT) the leading wireless medical technology company focused on the delivery of health information to improve quality of life ...
05/06/16 03:04 PMBIOTELEMETRY, INC. Files SEC form 8-K, Change in Directors or Principal Officers, Submission of Matters to a Vote of -
05/06/16 08:03 AMCan The Uptrend Continue for BioTelemetry (BEAT)? -
05/04/16 07:39 AMWhy BioTelemetry (BEAT) Stock Might be a Great Pick -
05/03/16 08:16 AMLooking for a Top Momentum Stock? 3 Reasons Why BioTelemetry (BEAT) is a Great Choice -
05/02/16 09:57 PMBioTelemetry, Inc. (BEAT) Reports Strong Q116 Results - Street Register - BioTelemetry, Inc. (BEAT) Reports Strong Q116 ResultsStreet RegisterBioTelemetry, Inc. (BEAT) surged 2.28% to $15.73 and the amount of shares that traded hands from sellers to buyers was 568,697 shares. The company declared its Q116 earnings after market closing on 26 April 2016. BEAT stock traded between $12.06 and ...Latest Analyst Ratings For BioTelemetry, Inc. (NASDAQ:BEAT)Share Trading Newsall 2 news articles »
05/02/16 09:44 AMAcadia Healthcare (ACHC) Beats on Q1 Earnings; Stock Up -
05/02/16 02:50 AMLatest Analyst Ratings For BioTelemetry, Inc. (NASDAQ:BEAT) - Share Trading News - Latest Analyst Ratings For BioTelemetry, Inc. (NASDAQ:BEAT)Share Trading NewsBioTelemetry, Inc. has a 50 day moving average of 12.12 and a 200 day moving average of 11.95. The stock's market capitalization is 430.81M, it has a 52-week low of 7.86 and a 52-week high of 16.96. The share price of the company (NASDAQ:BEAT) was ...
04/30/16 12:04 PMBIOTELEMETRY, INC. Financials -
04/29/16 01:43 PMETF’s with exposure to BioTelemetry, Inc. : April 29, 2016 -
04/29/16 07:50 AMBioTelemetry (BEAT) in Focus: Stock Jumps 6.4% in Session -
04/28/16 09:52 PMEarnings per share Overview of the Stock: BioTelemetry, Inc. (NASDAQ:BEAT) - News Oracle - Earnings per share Overview of the Stock: BioTelemetry, Inc. (NASDAQ:BEAT)News OracleLast Trade: The Company rose 15.50% and finished at $14.46. The daily volume was measured at 1.07 million shares. The 52-week high of the share price is $16.96 and the 52-week low is $7.86. The company has a market cap of $349.24 million. The stock ...and more »
04/28/16 09:52 PMQ1 beat propels BioTelemetry; shares up 31% for the week - Seeking Alpha - Q1 beat propels BioTelemetry; shares up 31% for the weekSeeking AlphaThinly traded micro cap BioTelemetry (BEAT +7.3%) continues its earnings beat-stoked up move. Shares are up 31% since Monday. On Tuesday, the company reported EPS of $0.20 on revenues of $48.6M, both above consensus. It also upped its 2016 ...BioTelemetry, Inc. (BEAT) Raised to Strong-Buy at Zacks Investment ResearchWeb Breaking Newsall 3 news articles »
04/28/16 03:24 PMBioTelemetry, Inc.: Leads amongst peers with strong fundamentals -
About BioTelemetry

BioTelemetry logoBioTelemetry, Inc. (BioTelemetry), formerly CardioNet, Inc., provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. The Company operates in three segments: patient services, product and research services. The patient services business segment's principal focus is on the diagnosis and monitoring of cardiac arrhythmias or heart rhythm disorders, through its core Mobile Cardiac Outpatient Telemetry(MCOT), event and Holter services in a healthcare setting. The product business segment focuses on the development, manufacturing, testing and marketing of medical devices to medical companies, clinics and hospitals. The Company's research services focuses on providing cardiac safety monitoring services for drug and medical treatment trials in a research environment. In August 2012, the Company completed the acquisition of Cardiocore Lab, Inc. (Cardiocore).

Industry, Sector and Symbol:
  • Sector: Healthcare
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: BEAT
  • CUSIP:
Key Metrics:
  • Previous Close: $16.29
  • 50 Day Moving Average: $16.07
  • 200 Day Moving Average: $12.86
  • P/E Ratio: 40.23
  • P/E Growth: 0.00
  • Market Cap: $443.24M
  • Current Quarter EPS Consensus Estimate: $0.71 EPS
Additional Links:
BioTelemetry (NASDAQ:BEAT) Chart for Thursday, June, 30, 2016


            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by StockTwits As Featured by Seeking Alpha